PROCEPT BioRobotics Co. (NASDAQ:PRCT) Receives $90.00 Average PT from Brokerages
Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the seven research firms that are covering the company, Marketbeat.com reports. One research analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12-month […]
